10% owner Kevin Tang buys 122,416 shares for $1.8M across 3 transactions, raising stake to 372K shares amid 153.6% 30-day rally.
Kevin Tang, a 10% owner of Singular Genomics, executed 3 separate purchases totaling 122,416 shares for $1,806,219.84 between September 16–18, with a blended average price of $14.75, increasing his holdings by 49.0% to 372,000 shares. The timing coincides with pronounced positive price momentum: the stock has risen 153.6% over 30 days and 74.4% over 90 days, now trading at $16.79 near its 52-week high of $18.30. However, the company remains unprofitable ($-21.3M net income) with minimal trailing-quarter revenue ($737.0K), though it posted 280.5% annual revenue growth. Tang's own cross-ticker track record shows 20 prior buys with a 30.00% 90-day win rate and average 90-day return of -1.9%, suggesting his historical purchasing decisions have not consistently outperformed the market. The magnitude and timing of this accumulation warrant examination of what conditions or information motivated a 49% position increase during an already-elevated valuation period.